STAGE III DIFFUSE LARGE B-CELL LYMPHOMA

Clinical trials for STAGE III DIFFUSE LARGE B-CELL LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new STAGE III DIFFUSE LARGE B-CELL LYMPHOMA trials appear

Sign up with your email to follow new studies for STAGE III DIFFUSE LARGE B-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for Tough-to-Treat lymphoma: early trial tests powerful drug cocktail

Disease control Ongoing

This early-stage study is testing a new combination of drugs for patients with an aggressive type of lymphoma (DLBCL) that has returned or not responded to previous treatment. Researchers are adding a drug called carfilzomib to a standard chemotherapy regimen to see if it's safe,…

Matched conditions: STAGE III DIFFUSE LARGE B-CELL LYMPHOMA

Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

STAGE III DIFFUSE LARGE B-CELL LYMPHOMA

Get alerted when new STAGE III DIFFUSE LARGE B-CELL LYMPHOMA trials appear

New hope for Tough-to-Treat lymphoma: early trial tests powerful drug cocktail